UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 99 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,000 | -26.9% | 45,951 | 0.0% | 0.00% | – |
Q2 2022 | $26,000 | +36.8% | 45,951 | +264.9% | 0.00% | – |
Q4 2021 | $19,000 | -50.0% | 12,594 | 0.0% | 0.00% | – |
Q3 2021 | $38,000 | -94.3% | 12,594 | -91.2% | 0.00% | – |
Q2 2021 | $667,000 | -50.9% | 143,577 | -36.6% | 0.00% | – |
Q1 2021 | $1,359,000 | +18.4% | 226,402 | +3.4% | 0.00% | – |
Q4 2020 | $1,148,000 | +58.1% | 218,966 | +4.4% | 0.00% | – |
Q3 2020 | $726,000 | -55.6% | 209,782 | +11.4% | 0.00% | -100.0% |
Q2 2020 | $1,635,000 | +68.2% | 188,359 | +12.5% | 0.00% | 0.0% |
Q1 2020 | $972,000 | -14.4% | 167,414 | +6.4% | 0.00% | 0.0% |
Q4 2019 | $1,135,000 | +23.5% | 157,403 | +4.6% | 0.00% | 0.0% |
Q3 2019 | $919,000 | +40.1% | 150,502 | +118.2% | 0.00% | – |
Q2 2019 | $656,000 | +31.5% | 68,983 | +12.1% | 0.00% | – |
Q1 2019 | $499,000 | -49.8% | 61,520 | +0.6% | 0.00% | -100.0% |
Q4 2018 | $994,000 | +167.9% | 61,125 | +169.0% | 0.00% | – |
Q3 2018 | $371,000 | +20.1% | 22,725 | +11.0% | 0.00% | – |
Q2 2018 | $309,000 | – | 20,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |